Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...
According to Research by , MicroRNA Market Growth is Driven by Rising Prevalence of Cancer and Advances in Genomic ...
30m
In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...
September is the perfect time to turn up the volume on conversations about Primary Biliary Cholangitis (PBC) and the symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback